CANNABIS, STRATEGIES

John Arbuthnot

CEO,

Delta 9 Cannabis

  • Delta 9 Cannabis Inc. Is among the Premier Cannabis Companies in Canada
  • CEO & Founder of Delta 9 Cannabis
  • The First Company Licensed to Produce & Sell Medical Marijuana in Manitoba

About John

John Arbuthnot, CEO, has built Delta 9 Cannabis into three separate business units:

  • Cultivation, branded products, and wholesale
  • Sixteen retail stores
  • B2B - selling turn key grow pods, genetics, and consulting services

John's Videos

Delta 9 Cannabis' revenue for the 2nd quarter of 2021 was up 29% to $16.75 million, compared with:

  • $13.23 million for the first quarter of 2021.
  • $13.01 million for the second quarter of 2020.
  • Delta 9 revenues for the six-month period ending June 30, 2021, was $30 million up 21%, compared to $24.76 million for the same period last year.

Delta 9's chief executive officer, John Arbuthnot, was very proud of the company's Q2, 2021 results, with record top-line revenues and a seventh consecutive quarter of positive Adjusted EBITDA. Delta 9 will:

  • Continue to grow its brick-and-mortar and online retail business strategy.
  • Expand its turnkey Grow Pod sales into the US market with new cultivation partners.
  • Continue to lower its cost of production which is currently at $0.65 per gram.

All three business units contributed to Delta 9's record revenue this quarter. The company anticipates continued growth in all three of its business segments units through the back half of 2021.

Delta 9 Cannabis placed 7th out of 448 participants on The Globe and Mail's third annual ranking of Canada's top-growing Canadian companies. The survey ranked 448 participants based on three-year revenue growth. Delta 9 Cannabis earned its spot with three-year revenue growth of 5,413%.



Delta 9 Cannabis anticipates revenue for the three-month period ending June 30th, 2021 to be between $15.5 million and $17.25 million, an increase of up to a 33% (on the high end), compared with:

  • $13.23 million for the first quarter of 2021
  • $13.01 million for the second quarter of 2020
  • Delta 9 anticipates revenues for the six-month period ending June 30, 2021, to be between $28.75 million and $30.5 million, compared to $24.76 million for the same period last year.

Delta 9's chief executive officer, John Arbuthnot, commented recently that Delta 9 anticipates its Q2 2021 financial results will demonstrate a record revenue quarter for Delta 9 with the company's three business segments contributing to the success of the quarter. Delta 9 anticipates continued growth in all three of our business segments units through the back half of 2021.



Delta 9 is a vertically integrated cannabis company with three revenue streams: cultivation/wholesale, retail stores, and B2B business selling turnkey grow pods growing platforms. The company's three-prong growth strategy for revenue going forward will focus on expanding its retail store network from 12 to 20 stores this year and continue to market its low-price leadership strategy at new and existing stores.

Delta 9 will continue to build momentum in the cannabis wholesale segment with costs per gram at $0.67 and focus on expanding product distribution in its seven provincial markets. It will also continue to sell its turnkey growing platforms in the Canadian micro cultivation industry and expansion into emerging US market.

Management is confident that its specific focus on revenue growth, gross profitability, and prudent cost controls will provide earnings growth over the coming quarters.


Delta 9 is a vertically integrated cannabis company with three revenue streams: cultivation/wholesale, retail stores, and B2B business selling grow pods, genetics, and consulting services.

The company's three-prong growth strategy for revenue going forward will focus on expanding its retail store network and continue to market its low-price leadership strategy at new and existing stores. Delta 9 will continue to build momentum in the cannabis wholesale segment with a focus on expanding product distribution in its seven provincial markets and continue to expand B2B business with a focus on creating relationships in the Canadian micro cultivation industry and expansion into emerging markets in the USA.

Management is confident that its specific focus on revenue growth, gross profitability, and prudent cost controls will provide earnings growth over the coming quarters.